Temperature Excursion During Pharmaceutical Transit: Who Bears the Financial Loss

A temperature excursion during pharmaceutical transit puts a series of parties under the spotlight. The overseas manufacturer who released the product. The forwarder who packed and consolidated it. The air or sea carrier who moved it. The transshipment handler who lifted it. The customs broker who cleared it. The trucking company who took it the last mile. Each of these parties has a contractual relationship with the goods, a liability framework, and a documentation trail.

The question that determines whether the NPRA-licensed importer recovers the loss is not which party caused the excursion. It is which party bears the financial loss when the cargo arrives damaged. In nearly every case under the contractual structures common in pharmaceutical trade into Malaysia, that party is the importer. This guide walks through the liability allocation that produces that outcome, and the cargo insurance position that responds to it.

Key Facts: Temperature Excursion Liability for Pharmaceutical Imports

Who carries insurable interest on the cargo during transit? The party who bears the economic exposure to physical loss or damage. Under Incoterms 2020, risk transfers from seller to buyer at the origin port for CIF and CIP, and on board the vessel for FOB and CFR (International Chamber of Commerce, Incoterms 2020). For pharmaceutical imports into Malaysia, the NPRA Import Licence holder is the party carrying insurable interest from the moment of risk transfer through to delivery at the GDP-certified Malaysian warehouse.

What is the air carrier's liability for a temperature excursion? Under the Montreal Convention 1999, the air carrier's liability is capped at 26 SDR per kilogramme of gross weight, effective 28 December 2024 under the ICAO five-year inflation review (approximately $35 per kilogramme at April 2026 rates). Recovery requires proof that the carrier caused the loss. The cap applies regardless of cargo value.

What is the sea carrier's liability for a temperature excursion? Under the Hague-Visby Rules, the carrier's liability is capped at SDR 666.67 per package or 2 SDR per kilogramme, whichever is higher (approximately $900 per package or $2.70 per kilogramme at April 2026 rates). Recovery requires proof of carrier fault under the bill of lading and the convention.

What is the freight forwarder's liability for a temperature excursion? Generally lower than the cargo's commercial value. Forwarders typically operate under contractual liability terms that limit recovery to a multiple of freight charges or a per-kilogramme cap, not to the cargo's value. See why your freight forwarder is not your insurer for the framework.

What is the overseas supplier's liability after risk transfer? Under standard Incoterms 2020 risk allocation, generally none after the risk transfer point. The supplier retains pre-loading exposure and any contingent exposure under their own forwarder's liability where they arranged shipping, but the contractual link to the cargo loss runs through the importer's policy, not the supplier's.

Who bears the financial loss when the cargo arrives temperature-damaged? In practice, the NPRA Import Licence holder. Carrier liability caps under both Montreal and Hague-Visby leave the bulk of cargo value uncovered by carrier recovery. Forwarder liability is similarly capped. The cargo insurance policy is the recovery vehicle, and the importer is the named insured.

For the underlying frameworks, see Incoterms 2020, Incoterms 2020 cargo insurance responsibility, and Institute Cargo Clauses.

Resource: Cargo Insurance Coverage Audit

Take the 9-question Cargo Insurance Coverage Audit to score your pharmaceutical cargo cover against the temperature excursion and liability recovery baseline. Free, no signup wall.

The Six Parties to a Pharmaceutical Transit and Their Liabilities

A typical pharmaceutical import into Malaysia routes through six parties between the overseas manufacturer's release point and the importer's Malaysian warehouse. Each carries a distinct liability framework.

The pattern is consistent across all six parties: liability framework limits are denominated in per-kilogramme or per-package units that bear no relationship to the cargo's commercial value. For pharmaceutical cargo, where per-kilogramme value commonly runs into the hundreds or thousands of dollars and biologic per-kilogramme value can be substantially higher, the carrier and intermediate liability framework recovers a small fraction of the loss.

The cargo insurance policy is the recovery vehicle that closes the gap. Marine Cargo Open Cover with a temperature deviation endorsement is the working placement structure for NPRA-licenced importers; for one-off pharmaceutical movements, Marine Cargo Insurance applies, and for biologic and high-value transits, Specialist High-Value Transit Insurance applies. For the industry view, see Pharmaceutical & Medical Devices Cargo Insurance.

How Insurable Interest Sits With the NPRA Import Licence Holder

The legal anchor for cargo insurance is insurable interest. Under marine insurance law (codified in the Marine Insurance Act 1906 for the English law jurisdiction that most marine policies still default to), the insured must have an insurable interest in the cargo at the time of loss for the policy to respond.

For pharmaceutical imports into Malaysia, the NPRA Import Licence holder carries insurable interest because the licence holder bears the economic exposure to physical loss or damage once risk transfers. The mechanics of that exposure run through three legal layers.

The NPRA Import Licence itself identifies the company that is authorised to import the registered product. The licence is in the licence-holding company's name; the cargo, once it arrives in Malaysia, can only legally be supplied or sold by wholesale by that licence holder. The licence holder's commercial position depends on the cargo arriving in saleable condition.

The Incoterms 2020 risk transfer point determines when economic risk passes from the overseas seller to the Malaysian buyer. Under CIF and CIP, risk transfers at the origin port when goods are loaded; under FOB and CFR, risk transfers on board the vessel at the origin port. From that point forward, the importer carries the economic exposure to physical loss or damage in transit.

The contractual relationship with the cargo typically runs through purchase, with title passing at terms agreed in the sale contract. For pharmaceutical product, title commonly passes with the bill of lading or airway bill or against payment, with the importer becoming the legal owner of the goods at a defined point in the transit chain.

Insurable interest typically attaches at or before the risk transfer point. By the time the cargo is on board the vessel or in the air carrier's hold, the importer is both the party with economic exposure and the party with title or contractual right to the goods. That is the legal basis for the cargo insurance policy responding to the importer's loss.

Why Carrier Liability Recovery Is Not the Answer

The natural reaction to a temperature excursion claim is to pursue the carrier whose handling caused the excursion. The cargo insurance policy itself often pursues subrogation against the carrier after paying the insured. From the importer's direct recovery perspective, however, carrier liability is rarely a meaningful primary recovery route.

Take air freight first. The Montreal Convention 1999 caps the air carrier's liability at 26 SDR per kilogramme of gross weight (effective 28 December 2024 under the ICAO five-year inflation review). At April 2026 SDR-USD rates of approximately $1.35, that is approximately $35 per kilogramme. The cap applies to most cargo claims by default and can only be exceeded by a special declaration of value at the time of shipment, which is rarely done in practice because of the additional freight rates that result.

For a 200-kilogramme biologic pallet, the maximum carrier recovery is approximately $7,000. For a biologic consignment commonly valued in the high five figures to low six figures, the carrier recovery covers a small fraction of the loss. The cargo insurance policy is the recovery vehicle for the remainder.

Sea freight runs on the Hague-Visby Rules, with the carrier's liability capped at SDR 666.67 per package or 2 SDR per kilogramme of gross weight, whichever is higher (approximately $900 per package or $2.70 per kilogramme at April 2026 rates). The same dynamic applies: per-package or per-kilogramme caps that bear no relationship to the cargo's commercial value. Recovery also requires proof of carrier fault, which is more difficult to establish than a cargo insurance claim under all-risks Institute Cargo Clauses (A) 2009 cover.

Freight forwarder liability is similarly bounded. FIATA Model Rules and BIFA Standard Trading Conditions, which underpin most forwarder relationships in international pharmaceutical trade, impose liability limits typically expressed as a multiple of freight charges or a per-kilogramme cap. The exact figure depends on the trading conditions in force, but the practical recovery from the forwarder is generally well below cargo value.

The Three Excursion Scenarios and the Recovery Path

Three excursion scenarios cover the majority of pharmaceutical temperature deviation claims into Malaysia.

Scenario 1: Reefer Unit Failure on Sea Freight

A pharmaceutical consignment moves on an active reefer container from an EU port to Port Klang. Mid-voyage, the reefer compressor fails. The temperature rises outside the registered stability range for the product before the vessel reaches a port where the unit can be repaired or replaced. The product is treated as out of specification on arrival.

Liability allocation: The sea carrier may be at fault for the reefer unit malfunction, but recovery under the Hague-Visby cap of SDR 666.67 per package or 2 SDR per kilogramme covers a fraction of cargo value. The freight forwarder, if there is one in the chain, has typically further-limited contractual liability.

Cargo insurance position: ICC (A) 2009 with a reefer equipment breakdown extension responds, subject to policy terms. Without the equipment breakdown extension, the base ICC (A) wording may not cover equipment failure as a covered peril cleanly. The cargo insurance policy then pursues subrogation against the carrier for the limited recovery available under Hague-Visby.

Scenario 2: Ground Handling Excursion on Air Freight Transshipment

A biologic consignment moves by air from an EU hub to KLIA via a regional transshipment point. During ground handling at the transshipment apron, the active temperature-controlled unit is left on the tarmac for several hours in high ambient temperature. The internal temperature breaches the registered stability range.

Liability allocation: The air carrier and the ground handler may be at fault. The Montreal Convention cap of 26 SDR per kilogramme of gross weight applies to the carrier; the ground handler's liability is generally contractual to the carrier or forwarder and not directly to the importer.

Cargo insurance position: ICC (A) 2009 with a temperature deviation endorsement responds, subject to policy terms. Montreal Convention gap cover, if endorsed on the policy, explicitly addresses the gap between the carrier liability cap and the cargo value. The cargo insurance policy is the practical recovery route; carrier recovery covers a small fraction.

Scenario 3: Customs Clearance Delay Causing Hold-Time Exceedance

A pharmaceutical consignment moves in a passive temperature-controlled pallet shipper with a qualified hold-time of 120 hours. Customs clearance delays at the Malaysian entry point extend the actual transit time beyond the qualified hold-time. The PCM is exhausted; internal temperature begins drifting; the product is out of specification on receipt.

Liability allocation: Customs clearance is a regulatory process; the customs authority is not commercially liable for clearance delays. The freight forwarder or customs broker may have facilitated the clearance but is not contractually liable for the regulatory clearance timing.

Cargo insurance position: The interaction with ICC (A) 2009 Clause 4.5 (delay exclusion) is the key issue. The delay exclusion excludes losses arising from delay even where the delay is caused by an insured peril, unless the policy is specifically endorsed to address delay. The pre-conditioning and hold-time exceedance treatment, negotiated at placement, is what determines whether the policy responds.

How the Cargo Insurance Policy Actually Becomes the Recovery Vehicle

The reason cargo insurance is the dominant recovery vehicle for pharmaceutical temperature excursion losses, rather than carrier liability recovery, comes down to four practical advantages.

1. No requirement to prove carrier fault. ICC (A) 2009 is all-risks cover. The policy responds to loss or damage from any cause not specifically excluded under Clauses 4 to 7, regardless of which party in the chain caused it. The importer does not need to litigate causation against the carrier; the policy responds, and the insurer pursues subrogation if appropriate.

2. Cover up to declared value, not capped at per-kilogramme limits. The cargo insurance policy responds up to the insured value declared at placement, subject to per-shipment limits. This recovers the actual cargo value, including the replacement cost considerations discussed in the biologics article.

3. Speed of settlement. Cargo insurance claims, where documentation is complete, settle within weeks. Carrier liability recovery typically requires litigation or arbitration under the relevant convention and can take materially longer.

4. Importer is the named insured. The cargo insurance policy is in the importer's name. The recovery flows directly to the party who bears the financial loss, rather than through any other party in the chain.

If your cargo arrives temperature-damaged, the recovery vehicle is the cargo insurance policy.

Voyage arranges open cover marine cargo insurance for NPRA-licensed pharmaceutical importers, with temperature deviation, reefer equipment breakdown, and Montreal Convention gap cover negotiated at placement. Request a coverage review at voyagecover.com/#contact-form or WhatsApp Kevin at +60 19 990 2450.

The CIF and CIP Trap on Pharmaceutical Imports

Where the overseas supplier arranges shipping on CIF or CIP terms, the supplier obtains an insurance certificate for the importer's benefit. Under Incoterms 2020, CIF requires Institute Cargo Clauses (C) minimum (the most restrictive named-perils cover) and CIP requires Institute Cargo Clauses (A) minimum (the broadest all-risks cover, which was upgraded from (C) to (A) in the 2020 revision).

The trap on pharmaceutical CIF imports is that ICC (C) is rarely fit for purpose for pharmaceutical cargo. Named perils cover (fire, explosion, vessel stranding, collision, jettison, general average sacrifice) does not address temperature deviation, sterility breach, regulatory rejection, or many of the operational failure modes that cause pharmaceutical losses. The importer who relies on the CIF certificate alone for cover discovers the gap at claim.

The practical fix is to purchase top-up cover bringing the insurance scope to ICC (A) 2009 with pharmaceutical endorsements, with the importer's own placement responding to the gap between the supplier's CIF certificate and the actual cargo insurance need. Several Malaysian pharmaceutical importers running CIF programmes maintain a parallel top-up open cover for exactly this reason.

Frequently Asked Questions

Who carries insurable interest on the cargo during transit?

The party who bears the economic exposure to physical loss or damage. For pharmaceutical imports into Malaysia, that is the NPRA Import Licence holder, from the moment risk transfers under the contractual Incoterm (origin port under CIF or CIP, on board the vessel under FOB or CFR) through to delivery at the GDP-certified Malaysian warehouse.

How much can I recover from the air carrier for a temperature excursion?

Under the Montreal Convention 1999, the air carrier's liability is capped at 26 SDR per kilogramme of gross weight, effective 28 December 2024 under the ICAO five-year inflation review (approximately $35 per kilogramme at April 2026 rates). The cap can only be exceeded by a special declaration of value at shipment, which is rarely done. Recovery also requires proof of carrier fault.

How much can I recover from the sea carrier?

Under the Hague-Visby Rules, the carrier's liability is capped at SDR 666.67 per package or 2 SDR per kilogramme of gross weight, whichever is higher (approximately $900 per package or $2.70 per kilogramme at April 2026 rates). Recovery requires proof of carrier fault under the bill of lading and the convention. For the underlying convention, see Hague-Visby Rules.

What about the freight forwarder?

Freight forwarder liability is bounded by the contractual standard trading conditions in force (FIATA Model Rules, BIFA, FMFF, or similar). Liability is typically expressed as a multiple of freight charges or a per-kilogramme cap, well below cargo value. The forwarder is not the importer's insurer; see why your freight forwarder is not your insurer for the framework.

Does the overseas supplier carry any liability after the goods are loaded?

Under standard Incoterms 2020 risk allocation, generally no. The supplier retains pre-loading exposure and any contingent exposure where the supplier arranged shipping under CIF or CIP, but the contractual link to the cargo loss runs through the importer's policy from the risk transfer point onwards.

Is the CIF certificate from my overseas supplier sufficient for pharmaceutical cargo?

Rarely. CIF requires Institute Cargo Clauses (C) minimum under Incoterms 2020, which is the most restrictive named-perils cover and does not address temperature deviation, sterility breach, or many operational pharmaceutical failure modes. The practical fix is to purchase top-up cover bringing the insurance scope to ICC (A) 2009 with pharmaceutical endorsements, with the importer's own placement responding to the gap.

What happens if a temperature excursion is caused by customs clearance delay?

Customs authorities are not commercially liable for regulatory clearance delays. The cargo insurance policy is the recovery route, subject to the interaction with ICC (A) 2009 Clause 4.5 (delay exclusion) and any specific delay endorsement on the policy. Pre-conditioning and hold-time exceedance treatment, negotiated at placement, is the key for passive container shipments where regulatory delays cause hold-time breach.

How does the cargo insurance policy actually pay out on a temperature excursion claim?

The importer submits the documentation pack (logger data, chain-of-custody handover records, GDP certification at origin, carrier's protest note, surveyor's report, NPRA destruction certificate where applicable, and the policy documentation). The insurer's loss adjuster reviews the documentation against the policy terms and conditions. Where the loss is covered, the insurer pays the importer the agreed value (subject to deductibles and policy limits) and may then pursue subrogation against any responsible party in the chain.

Voyage Conclusion

The financial loss on a pharmaceutical temperature excursion falls on the NPRA Import Licence holder, almost regardless of which party in the transit chain caused the excursion. Carrier liability under Montreal and Hague-Visby caps at per-kilogramme limits that bear no relationship to cargo value. Forwarder liability is similarly bounded. The cargo insurance policy is the recovery vehicle, and the importer is the named insured.

Talk to Voyage about Marine Cargo Open Cover for cold-chain pharmaceutical importers, with temperature deviation, reefer equipment breakdown, and Montreal Convention gap cover negotiated at placement. For high-value transits, Specialist High-Value Transit Insurance applies. For the industry view, see Pharmaceutical & Medical Devices Cargo Insurance. WhatsApp +60 19 990 2450 or use the contact form.

Take the Cargo Insurance Coverage Audit

Score your pharmaceutical cargo programme: Cargo Insurance Coverage Audit. Free, no signup wall.

Related in the pharmaceutical cluster: pharmaceutical imports cargo insurance cluster hub, cold chain pharmaceutical transport in Malaysia, cargo insurance pharmaceutical exclusions, plus the broader foundational guides: Institute Cargo Clauses and LC insurance certificate requirements.

Disclaimer: This article provides general guidance on liability allocation and cargo insurance recovery for pharmaceutical temperature excursion losses as of May 2026. Carrier liability frameworks (Montreal Convention 1999, Hague-Visby Rules), forwarder standard trading conditions, and Incoterms 2020 are international conventions and may be supplemented by jurisdiction-specific rules.

Coverage terms, conditions, and availability vary by insurer, policy, and jurisdiction. Always review your specific policy wording and consult a qualified insurance or legal professional before making coverage decisions.